Concepedia

Spiros Georgakis

SG

Statistics

Publications

2

Citations

53

H-Index

2

Active since

2023

Affiliations

Glucox Biotech (Sweden)(Current)

University of Crete

Spiros Georgakis is an author at Glucox Biotech (Sweden) specializing in topical ophthalmic medications, ocular disease, and reactive oxygen species injury.

Publications per year

2023–2024

2

Publications

2

Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy

Stavroula Dionysopoulou, Per Wikström, Claudio Bucolo et al. · Diabetes · 2023 · 42 citations · Full text

, , +15

Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina

Stavroula Dionysopoulou, Per Wikström, Erik Walum et al. · Pharmaceuticals · 2024 · 11 citations · Full text

, , +16

1–2 of 2